This is a $291,370,929.00 cost-plus-fixed-fee definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Merck Sharp & Dohme LLC, a subsidiary of Schering Plough Corporation and major pharmaceutical manufacturer. The contract has a period of performance through September 27, 2027 and is not set aside for any specific business category.
Merck has been awarded numerous prime contracts, subcontracts, and indefinite delivery vehicles (IDVs) by federal agencies like the Department of Veterans Affairs, Department of Defense, Department of Health and Human Services, and Department of Justice to supply pharmaceuticals, vaccines, and related services. This includes treatments for COVID-19, cancer, hepatitis, influenza, measles, mumps, rubella, meningitis, and other diseases. Merck provides adult and pediatric vaccines through programs like Vaccines for Children and Section 317(j) immunization grants to the Centers for Disease Control and Prevention (CDC) and state health departments. The company also collaborates as a subcontractor on medical countermeasure programs administered by the Biomedical Advanced Research and Development Authority (BARDA).
Generated 6/28/24, 10:19 AM